Safeguarding Data Integrity in Pharmaceutical Manufacturing
Journal of Advances in Medical and Pharmaceutical Sciences · pp. 64–75 · Published 17 Aug 2024
10.9734/jamps/2024/v26i8708Abstract
Aims: Comprehensively analyze data integrity challenges in the pharmaceutical industry, analyze regulatory observations, and propose mitigation strategies for ensuring compliance with current good manufacturing practices (cGMP), particularly for electronic data and computerized systems. Study Design: Analysis of regulatory documents, industry-standard guides, and case studies. Methodology: The study involved a comprehensive review of FDA guidance documents, warning letters, and Form 483 observations related to data integrity. Case studies of non-compliance were analyzed to identify common issues and consequences. Technical, organizational, and behavioral factors contributing to data integrity problems were examined. Mitigation strategies and best practices were compiled based on industry guidelines and expert recommendations. Results: Data integrity violations often involve data falsification, poor retention, and electronic record manipulation. Non-compliant firms have faced severe penalties for non-compliance. Challenges include legacy systems, complex data management, inadequate training, and global supply chains. Mitigation strategies involve data governance, risk-based validation, access controls, comprehensive training, and advanced technologies like blockchain. Conclusion: Data integrity remains a critical challenge in the pharmaceutical industry, requiring a holistic approach that combines technological solutions with organizational and cultural best practices. Implementing robust data governance systems, fostering a quality culture, and leveraging advanced technologies can significantly improve compliance and reduce risks associated with data integrity issues.
References (21)
- 1 Smart Pharmaceutical Manufacturing: Ensuring End-to-End Traceability and Data Integrity in Medicine Production [DOI]
- 2 Data integrity within the biopharmaceutical sector in the era of Industry 4.0 [DOI]
- 3 Data integrity issues in pharmaceutical industry: Common observations, challenges and mitigations strategies [DOI]
- 4 Impact of GAMP 5, data integrity and QbD on quality assurance in the pharmaceutical industry: How obvious is it? [DOI]
- 5 Data Integrity: History, Issues, and Remediation of Issues [DOI]
- 6 Data Integrity in Global Clinical Trials: Discussions From Joint US Food and Drug Administration and UK Medicines and Healthcare Products Regulatory Agency Good Clinical Practice Workshop [DOI]
- 7 Digital Transformation Strategies to Strengthen Quality and Data Integrity in Pharma [DOI]
- 8 Blockchain for Data Originality in Pharma Manufacturing [DOI]
- 9 Digital Transformation in the Pharmaceutical Industry: Ensuring Data Integrity and Regulatory Compliance [DOI]
- 10 Provable Data Integrity in the Pharmaceutical Industry based on Version Control Systems and the Blockchain [DOI]
- 11 Data Integrity Violations: A Challenge to the Pharmaceutical Industry [DOI]
- 12 Pharmaceutical Data Integrity: issues, challenges and proposed solutions for manufacturers and inspectors [DOI]
- 13 Good Manufacturing Practices for Pharmaceuticals [DOI]
- 14 Data Integrity in the Pharmaceutical Industry: Analysis of Inspections and Warning Letters Issued by the Bioresearch Monitoring Program Between Fiscal Years 2007–2018 [DOI]
- 15 Towards a Computational Approach for the Assessment of Compliance of ALCOA+ Principles in Pharma Industry [DOI]
- 16 A Recent Regulatory Update on Consequences of Data Integrity Issues and its Management in Pharmaceutical Scenario [DOI]
- 17 Analytics and Blockchain for Data Integrity in the Pharmaceuticals Industry [DOI]
- 18 Documentation and Data Integrity in Pharmaceutical Industry [DOI]
- 19 Raw Data Management and Data Integrity in Pharmaceutical Product Development [DOI]
- 20 Data Integrity Implementation Strategy for Pharma Industry
- 21 Maintaining Data Integrity [DOI]
Cited by 18
Monali Rushi Dakhole, Kalyani Ramprasad Thombre, Krishna Radheshyam Gupta · Annales Pharmaceutiques Françaises · 2026
Pravin Ullagaddi · Journal of Computer and Communications · 2025
Pravin Ullagaddi · Journal of Computer and Communications · 2024
Janne Harkonen, Javier Mauricio Guerrero Rodriguez, Erno Mustonen · Eng · 2024
Christina Stroh, Terry Oroszi · Open Journal of Leadership · 2024
Showing 5 of 18 known citations — external sources report more than can currently be individually listed.
Related research
- Exploring the Challenges of Artificial Intelligence in Data Integrity and its Influence on Social Dynamics — shares topic coverage
- Blockchain and Cybersecurity Integration for Secure and Resilient Agricultural Supply Chains in the United States — shares topic coverage
- Advancing Cloud Technology Security: Leveraging High-Level Coding Languages like Python and SQL for Strengthening Security Systems and Automating Top Control Processes — shares topic coverage
- Governance Frameworks for Ensuring Algorithmic Decision Data Integrity in AI Systems and Regulatory Compliance — shares topic coverage
- Real-Time Data Governance and Compliance in Cloud-Native Robotics Systems — shares topic coverage
Article metrics
Real usage data collected on this platform.
28
Page views
0
PDF downloads
4
Outbound clicks
18
Citations
Views over time
Views by country
Approximate, from request IP at view time — not citizenship or institution. Countries with fewer than 5 views are grouped as "Other".
Traffic sources
Referring site, by host.
Views and downloads exclude known bots/crawlers. Citations combines this platform's own DOI-resolved index with each external source's own reported total — see Cited by above for individually listed citing works. Last refreshed 0 seconds ago.